DCM
FOMX

Driehaus Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Driehaus Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-598,792
Closed -$3M – 582
2018
Q2 		$3M Buy
598,792
+10,032
+2% +$51.6K 0.1% 225
2018
Q1 		$3.02M Buy
588,760
+40,718
+7% +$245K 0.11% 214
2017
Q4 		$3.29M Buy
548,042
+16,475
+3% +$99.1K 0.13% 206
2017
Q3 		$2.95M Buy
531,567
+22,032
+4% +$114K 0.12% 209
2017
Q2 		$2.36M Buy
509,535
+77,137
+18% +$344K 0.09% 236
2017
Q1 		$2.14M Sell
432,398
-366,193
-46% -$3.52M 0.07% 257
2016
Q4 		$8.86M Buy
798,591
+8,475
+1% +$79.7K 0.31% 68
2016
Q3 		$7.32M Buy
790,116
+176,880
+29% +$1.48M 0.25% 87
2016
Q2 		$3.89M Sell
613,236
-4,871
-0.8% -$32.3K 0.14% 159
2016
Q1 		$4.03M Sell
618,107
-22,271
-3% -$144K 0.13% 157
2015
Q4 		$5.19M Buy
640,378
+91,654
+17% +$685K 0.18% 131
2015
Q3 		$4.02M Buy
548,724
+171,108
+45% +$1.74M 0.15% 165
2015
Q2 		$3.87M Buy
377,616
+56,874
+18% +$629K 0.13% 193
2015
Q1 		$2.97M Buy
320,742
+107,062
+50% +$958K 0.1% 252
2014
Q4 		$1.5M Buy
+213,680
New +$1.22M 0.06% 360

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Driehaus Capital Management's FOMX Position: Q3 2018 in Review

Driehaus Capital Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2018, closing a stake of 598,792 shares — an estimated $3M sold.

Driehaus Capital Management first reported a position in FOMX in Q4 2014 and held it in 15 quarters. The position peaked at $8.86M in Q4 2016. 75 funds tracked by Wall St. Rank hold FOMX as of Q3 2018.

  • Driehaus Capital Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2018 after selling out during the quarter.
  • Driehaus Capital Management sold 598,792 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2018, an estimated $3M.
  • Driehaus Capital Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2014 and held it in 15 quarters.
  • Driehaus Capital Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $8.86M in Q4 2016.
  • 75 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2018.

Based on Driehaus Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.